摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(phenylamino)pent-3-en-2-one | 26567-78-2

中文名称
——
中文别名
——
英文名称
4-(phenylamino)pent-3-en-2-one
英文别名
4-(phenylamino)-3-penten-2-one;4-phenylamino-3-pentene-2-one;4-Phenylamino-3-penten-2-one;4-anilinopent-3-en-2-one
4-(phenylamino)pent-3-en-2-one化学式
CAS
26567-78-2
化学式
C11H13NO
mdl
——
分子量
175.23
InChiKey
JLTWHWBUKGOPLH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    48-52 °C (lit.)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会发生分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 安全说明:
    S26,S36
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 储存条件:
    存放于阴凉干燥处

SDS

SDS:f49de5fcceae0dea1ba9d20c5ae51bb7
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Koenigs; Mengel, Chemische Berichte, 1904, vol. 37, p. 1330
    摘要:
    DOI:
  • 作为产物:
    描述:
    4-(cyclohexylamino)pent-3-en-2-one 以 neat (no solvent) 为溶剂, 反应 8.0h, 生成 4-(phenylamino)pent-3-en-2-one
    参考文献:
    名称:
    Novel Syntheses of Symmetric Alkyl-substituted β-Diketimines with Dimethylsulfate Assisted by Microwave
    摘要:
    我们提出了一种高效且新颖的对称${\beta}$-二酮亚胺的制备方法,该方法借助微波辅助进行。一系列N,N'-对称烷基取代的${\beta}$-二酮亚胺已通过二甲基硫酸与O-酰化反应合成。更高的重复性和产率、更低的成本以及由于无溶剂条件和更快的反应时间所带来的更高能量效率的绿色特性是这一新方法的主要优点。除了这些优点外,几乎所有类型的${\beta}$-二酮亚胺,包括较少报道的烷基取代${\beta}$-二酮亚胺,均已成功制备。预计这些化合物将在多个领域得到更广泛的应用。
    DOI:
    10.5012/bkcs.2013.34.10.2871
点击查看最新优质反应信息

文献信息

  • [EN] NITROGEN TITANIUM COMPLEX, CATALYTIC SYSTEM COMPRISING SAID NITROGEN TITANIUM COMPLEX AND PROCESS FOR THE (CO)POLYMERIZATION OF CONJUGATED DIENES<br/>[FR] COMPLEXE D'AZOTE TITANE, SYSTÈME CATALYTIQUE COMPRENANT LEDIT COMPLEXE D'AZOTE TITANE ET PROCÉDÉ DE (CO)POLYMÉRISATION DE DIÈNES CONJUGUÉS
    申请人:VERSALIS SPA
    公开号:WO2017017203A1
    公开(公告)日:2017-02-02
    Nitrogen titanium complex having general formula (I) or (II), wherein: - R1 represents a hydrogen atom; or is selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, optionally halogenated, cycloalkyl groups optionally substituted, aryl groups optionally substituted; - R2, R3, R4 and R5, identical or different, represent a hydrogen atom; or are selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, optionally halogenated, cycloalkyl groups optionally substituted, aryl groups optionally substituted, nitro groups, hydroxyl groups, amino groups; - Y represents a NH-R6 group wherein R6 represents a hydrogen atom, or is selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, optionally halogenated, cycloalkyl groups optionally substituted, aryl groups optionally substituted; or a N-R7 group wherein R7 is selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, optionally halogenated, cycloalkyl groups optionally substituted, aryl groups optionally substituted; - X1, X 2, X 3 and X 4, identical or different, represent a halogen atom, such as, for example, chlorine, bromine, iodine, preferably chlorine; or are selected from linear or branched C1 -C20 alkyl groups, preferably C1-C15, -OCOR8 or -OR8 groups wherein R8 is selected from linear or branched C1-C20 alkyl groups, preferably C1-C15; or one of X1, X2 and X3 is selected from ethers, such as,for example, diethylether, tetrahydrofuran (THF), dimethoxyethane, preferably tetrahydrofuran (THF); - n is 1 in the case wherein Y represents a NH-R6 group wherein R6 has the same meanings reported above; or is 0 in the case wherein Y represents a N-R7 group wherein R7 has the same meanings reported above, or in the case wherein one of X1, X2 and X3 is selected from ethers; - R'1, R' 2, R'3, R'4, R'5, R'6 and R'7, identical or different, represent a hydrogen atom; or are selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, optionally halogenated, cycloalkyl groups optionally substituted, aryl groups optionally substituted; - X'1 and X'2, identical or different, represent a halogen atom such as, for example, chlorine, bromine, iodine, preferably chlorine; or are selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, -OCOR'8 groups or -OR'8 groups wherein R' 8 is selected from linear or branched C1-C20 alkyl groups, preferably C1-C15; - Y' is selected from ethers such as, for example,diethylether, tetrahydrofuran (THF), dimethoxyethane, preferably is tetrahydrofuran (THF); or Y' represents a group having general formula (III), wherein R'1, R' 2, R'3, R'4, R'5, R'6 and R'7, have the same meanings as reported above; - m is 0 or 1. Said nitrogen titanium complex having general formula (I) or (II) can be advantageously used in a catalytic system for the (co)polymerization of conjugated dienes.
    氮钛配合物的一般化学式为(I)或(II),其中:- R1代表氢原子;或者选自线性或支链的C1-C20烷基,优选C1-C15,可选择卤代,环烷基可选择取代,芳基可选择取代;- R2、R3、R4和R5,相同或不同,代表氢原子;或选自线性或支链的C1-C20烷基,优选C1-C15,可选择卤代,环烷基可选择取代,芳基可选择取代,硝基,羟基,氨基;- Y代表NH-R6基团,其中R6代表氢原子,或选自线性或支链的C1-C20烷基,优选C1-C15,可选择卤代,环烷基可选择取代,芳基可选择取代;或N-R7基团,其中R7选自线性或支链的C1-C20烷基,优选C1-C15,可选择卤代,环烷基可选择取代,芳基可选择取代;- X1、X2、X3和X4,相同或不同,代表卤素原子,例如氯、溴、碘,优选氯;或选自线性或支链的C1-C20烷基,优选C1-C15,-OCOR8或-OR8基团,其中R8选自线性或支链的C1-C20烷基,优选C1-C15;或X1、X2和X3中的一个选自醚类化合物,例如二乙醚、四氢呋喃(THF)、二甲氧基乙烷,优选四氢呋喃(THF);- n在Y代表NH-R6基团的情况下为1,其中R6具有上述相同含义;或在Y代表N-R7基团的情况下为0,其中R7具有上述相同含义,或在X1、X2和X3中的一个选自醚类化合物的情况下为0;- R'1、R'2、R'3、R'4、R'5、R'6和R'7,相同或不同,代表氢原子;或选自线性或支链的C1-C20烷基,优选C1-C15,可选择卤代,环烷基可选择取代,芳基可选择取代;- X'1和X'2,相同或不同,代表卤素原子,例如氯、溴、碘,优选氯;或选自线性或支链的C1-C20烷基,优选C1-C15,-OCOR'8基团或-OR'8基团,其中R'8选自线性或支链的C1-C20烷基,优选C1-C15;- Y'选自醚类化合物,例如二乙醚、四氢呋喃(THF)、二甲氧基乙烷,优选四氢呋喃(THF);或Y'代表具有一般化学式(III)的基团,其中R'1、R'2、R'3、R'4、R'5、R'6和R'7具有上述相同含义;- m为0或1。具有一般化学式(I)或(II)的氮钛配合物可优势地用于共轭二烯的催化系统中的(共)聚合。
  • A closer look at ε-caprolactone polymerization catalyzed by alkyl aluminum complexes: the effect of induction period on overall catalytic activity
    作者:Hsi-Ching Tseng、Michael Y. Chiang、Wei-Yi Lu、Yen-Jen Chen、Cheng-Jie Lian、Yu-Hsieh Chen、Hsin-Yi Tsai、Yi-Chun Lai、Hsuan-Ying Chen
    DOI:10.1039/c5dt01563d
    日期:——
    Al complexes bearing ketimine ligands was investigated. The catalytic results indicated complexes with more steric hindrance with an electron-withdrawing group on the ligands, or the fact that less chelating ligands demonstrated greater propagation activity. The opposite trend for these structural effects was observed on the measurement of induction periods. These features on ligands of aluminum complexes
    先前对使用结构相关的铝配合物作为前催化剂的ε-己内酯的开环聚合的研究表明,总转化时间的趋势不一致。我们建议应考虑将Al络合物转化为真正的催化物质Al醇盐的诱导期,因为总转化时间包括诱导期和聚合物扩散时间。在此,研究了一系列带有酮亚胺配体的Al配合物的聚合速率。催化结果表明与配体上的吸电子基团具有更大空间位阻的配合物,或螯合配体较少的事实表明具有更大的传播活性。在诱导期的测量中观察到这些结构效应的相反趋势。铝配合物配体上的这些特征有助于促进向烷氧基铝的转化过程。总体催化性能应同时考虑诱导期和传播​​时间。
  • Liquid-Assisted Mechanosynthesis of trans-2,3-Dihydropyrroles from Chalcones and Enaminones
    作者:Hui Xu、Ze Zhang、Ming-Yue Weng、Hong Chen
    DOI:10.3987/com-20-14365
    日期:——
    iodine-promoted cyclization between chalcones and enaminones has been demonstrated under liquid-assisted grinding conditions. The present protocol provides a practical, fast and green alternative to traditional solvent-based methods due to its notable advantages such as significantly higher yield, much shorter reaction time, good functional group tolerance and mild reaction conditions.
    在液体辅助研磨条件下,通过碘促进查尔酮和烯胺酮之间的环化反应,可以有效合成各种反式-2,3-二氢吡咯。由于其显着的优点,例如明显更高的收率,更短的反应时间,良好的官能团耐受性和温和的反应条件,本协议为传统的基于溶剂的方法提供了一种实用,快速且绿色的替代方法。
  • SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES
    申请人:Caroff Eva
    公开号:US20110046089A1
    公开(公告)日:2011-02-24
    The present invention relates to compounds of formula I wherein R 1 , R 2 , R 4 , R 5 , R a , R b , n, W and Z are as defined in the application, their preparation and their use as P2Y 12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    本发明涉及式I化合物的制备及其用途,式中R1、R2、R4、R5、Ra、Rb、n、W和Z的定义如申请中所述,以及它们作为P2Y12受体拮抗剂用于治疗和/或预防外周血管、内脏血管、肝脏血管和肾脏血管、心血管和脑血管疾病或与血小板聚集相关状况的用途,包括人类和其他哺乳动物中的血栓症。
  • β‐Enaminone Synthesis from 1,3‐Dicarbonyl Compounds and Aliphatic and Aromatic Amines Catalyzed by Iron Complexes of Fused Bicyclic Imidazo[1,5‐ <i>a</i> ]pyridine Derived N‐Heterocyclic Carbenes
    作者:A. P. Prakasham、Manoj Kumar Gangwar、Prasenjit Ghosh
    DOI:10.1002/ejic.201800906
    日期:2019.1.17
    fused bicyclic imidazo[1,5‐a]pyridine framework of the type [CpFe(2‐R‐imidazo[1,5‐a]pyridin‐3‐ylidene)(CO)2]BF4 R = mesityl (1c), nPr (2c)} successfully carried out the synthesis of β‐enamino ketones (3–10) and (17–27) and β‐enamino esters (11–16) and (28–36) by the condensation of acyclic and cyclic 1,3‐dicarbonyl compounds and various aliphatic and aromatic amines in the presence of light irradiation
    一系列的Fe-NHC络合物(1 - 2)ç稠合的双环咪唑并[1,5-的一个]吡啶的类型的框架[CpFe的量(2-R -咪唑并[1,5-一个]吡啶-3-亚基)(CO)2 ] BF 4 R =异亚丙基丙酮(1C),ñ PR(图2c)}成功地进行了β烯氨基酮(合成3 - 10)和(17 - 27)和β-烯酯(11 – 16)和(28 – 36)在光照射下通过无环和环状1,3-二羰基化合物与各种脂肪族和芳香族胺的缩合而形成。相当显著,类型[CpFe的量(NHC)(acac)]的(的催化相关衬底加合物种类2E)和式[CpFe的量(NHC)(β的乘积加合物种类-烯胺酮)](2F所述的Fe的)已通过质谱研究检测到NHC前催化剂(2c)。[CpFe(2-R-咪唑并[1,5- a ]吡啶-3-亚基)(CO)2 ] BF 4 R =均三(1c),n Pr(2c)}络合物是从它们各自的N-杂环卡宾前体,即2-R-咪唑并[1
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐